You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 5, May 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Basic Science Seminars in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Molecular Basis for Understanding Neurotrophins and Their Relevance to Neurologic Disease

Steven G. Kernie, MD; Luis F. Parada, PhD

Arch Neurol. 2000;57:654-657.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The field of neurotrophin biology has made great advances in recent years to include a greater understanding of signaling pathways and broader understanding of the diverse biological roles of these molecules. This review will focus primarily on the nerve growth factor family of neurotrophins and how recent descriptions of the molecular function of both the ligands and the receptors have helped us to understand the basis for many neurologic processes. Ultimately, the goals of such studies are to give us further insight into potential diagnostic and therapeutic uses for these factors or signaling intermediates that may activate given pathways in neurotrophin signaling to achieve a particular objective based upon the underlying disease.

The prototypical neurotrophin is nerve growth factor (NGF), first described by Levi-Montalcini almost 50 years ago. The catalyst for her experiments was the observation that, in mouse sarcomas transplanted into . . . [Full Text of this Article]

NEUROTROPHIN RECEPTORS

NEUROTROPHIN PHYSIOLOGY

NEUROTROPHIN SIGNALING

RELEVANCE OF NEUROTROPHINS TO NEUROLOGIC DISEASE

THE FATE OF NEUROTROPHIN THERAPY FOR NEUROLOGIC DISEASE

From the Center for Developmental Biology (Drs Kernie and Parada) and Department of Pediatrics (Dr Kernie), University of Texas Southwestern Medical Center, Dallas.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(5):762-763.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuroprotective Effect of Granulocyte Colony-Stimulating Factor After Focal Cerebral Ischemia
Schabitz et al.
Stroke 2003;34:745-751.
ABSTRACT | FULL TEXT  

Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs
Hu et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2002;283:L494-L502.
ABSTRACT | FULL TEXT  

Neurotrophin-3 inhibits HCO3- absorption via a cAMP-dependent pathway in renal thick ascending limb
Good and George
Am. J. Physiol. Cell Physiol. 2001;281:C1804-C1811.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.